Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

  • There is currently no data for MSYS

Microsaic Wins R&D100 Award

25 Jun 2012 10:29

RNS Number : 0480G
Microsaic Systems plc
25 June 2012
 



Microsaic Systems plc

("Microsaic" or the "Company")

 

Microsaic Systems Wins R&D 100 Award for the World's Most Compact Mass Spectrometer

 

25 June 2012

 

Microsaic Systems plc (AIM: MSYS), the developer of chip-based scientific instruments, is proud to announce that its 3500 MiD mass spectrometer has been chosen as an R&D 100 award winner by an independent judging panel and the editors of R&D Magazine. The award recognises the 3500 MiD as one of the most technologically significant products to enter the marketplace in 2011. Microsaic is the first and only company to have commercialised MS (mass spectrometry) technology on a chip. The instrument distinguished itself among other entries as the chips allow production of MS detectors that are smaller, lighter, consume less energy, are easier to maintain and cheaper to run than conventional MS systems.

 

MS is widely accepted as one of the most reliable methods for identifying chemicals, and MS systems are used to accurately identify the chemicals that make up gaseous, liquid and solid samples. MS is used across a range of sectors including government, energy, utilities, pharmaceuticals, environmental, food & drink, healthcare and industrial chemicals. Although fast and sensitive, typical MS systems are large, heavy, energy intensive, expensive and complex to use; as a result, MS systems tend to be shared, central facilities. The 3500 MiD represents a step change in the ease of use and footprint of mass spectrometry.

 

Most revolutionary is the fact that the 3500 MiD, is fully self-contained, making it highly portable. Other commercial mass spectrometers have external vacuum pumps, which typically sit on the floor and connect to the instrument with vacuum hoses. The 3500 MiD's small size - about one third that of the main unit of typical competitors - means it can be easily incorporated within a stack or cluster of instruments on a particular chemist's work space, and is also small enough to sit inside a fume hood. This results in greater workplace productivity, by giving chemists access to immediate results, offering economic benefit in areas such as drug discovery and synthesis. It will also bring the accuracy and reliability of mass spectrometry to on-site analysis applications such as sports forensics, food & beverage quality, and oil and gas exploration.

 

"The awards have long been a benchmark of excellence so we are delighted to have been selected for the R&D 100 award - the competition has been strong this year so it is a great achievement to be acknowledged by industry leaders as one of the most valuable and significant products released to the market," said Professor Eric Yeatman, CEO of Microsaic Systems. "The 3500 MiD is the culmination of over a decade of research, bringing together two high tech fields - chemical analysis and silicon micro-engineering - to make possible a transformative capability in detection. Its low purchase, operating cost and small footprint, make the 3500 MiD deployable in a wide range of applications where mass spectrometry has not been able to reach until now - a true innovation."

 

 

Enquiries:

 

Microsaic Systems plc

Eric Yeatman, CEO

via Citigate Dewe Rogerson

Numis Securities Limited

Stuart Skinner (Nominated Adviser)

James Serjeant (Broker)

+44 (0)20 7260 1000

Citigate Dewe Rogerson (Financial PR)

Chris Gardner, Mark Swallow, Malcolm Robertson

+44 (0)20 7638 9571

The Scott Partnership (Trade PR)

Sarah Evans

+44 (0)1477 539540

About Microsaic Systems plc

Microsaic Systems develops chip-based scientific instruments for the identification of substances in solids, liquids and gases. The Company's products are based on the 'gold-standard' scientific technique of mass spectrometry (MS).

Microsaic Systems has developed a miniaturised mass spectrometer product, based on its patented, chip-based technologies (ionchip®, spraychip® and vac-chip™), that is smaller, lighter, quieter, more energy efficient and cheaper to run than conventional MS systems.

Mass spectrometry (MS) is used across multiple sectors, including government, energy, utilities, pharmaceutical, diagnostics and healthcare, environmental, food and drink, security and defence, and industrial chemicals - a combined market of $3.3 billion in 2010.

Microsaic Systems was established in 2001 by a team including founders from Imperial College London, and was admitted to AIM in April 2011 under the symbol MSYS.

www.microsaic.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRALIFFARDIEFIF
Date   Source Headline
26th Sep 20194:35 pmRNSPrice Monitoring Extension
23rd Sep 20197:00 amRNSInterim Results
4th Sep 20197:00 amRNSNotice of Results
12th Jun 20191:38 pmRNSAward of options
7th Jun 20197:00 amRNSDistribution Agreement with CM Corporation Ltd.
3rd Jun 20197:00 amRNSCost and time savings in manufacture of biologics
16th May 20192:06 pmRNSBoard Change
14th May 201912:00 pmRNSResult of AGM
14th May 201911:05 amRNSSecond Price Monitoring Extn
14th May 201911:00 amRNSPrice Monitoring Extension
14th May 20197:00 amRNSAGM Statement
2nd May 20197:00 amRNSDeepened collaboration with Chinese partner
12th Apr 20197:00 amRNSNotice of AGM and Posting of Annual Report
18th Mar 20197:00 amRNSOEM Agreement
11th Mar 20197:00 amRNSFinal Results
5th Mar 20197:00 amRNSInvestor Event
5th Mar 20197:00 amRNSMSYS jointly publishes bioprocessing data with MIT
19th Feb 20197:00 amRNSNotice of Results
11th Jan 20197:00 amRNSNew Protein Identification Product
19th Dec 201811:20 amRNSBioprocessing partnership update & trading update
7th Nov 20187:00 amRNSExclusive US and Canada Distribution Agreement
3rd Sep 20187:00 amRNSInterim Results
7th Aug 20187:00 amRNSNotice of Results
29th Jun 20184:12 pmRNSHolding(s) in Company
26th Jun 20182:04 pmRNSHolding(s) in Company
25th Jun 201810:10 amRNSDirectors' Interests
22nd Jun 201810:40 amRNSResult of GM, Completion of Fundraising & TVR
21st Jun 20187:00 amRNSDistribution Agreement with Amedis, spol. s ro.
13th Jun 20187:00 amRNSDistribution Agreement with Omicron Research Ltd.
6th Jun 20187:00 amRNSSuccessful Fundraising of £5.5 million
5th Jun 20184:46 pmRNSPrimaryBid.com Offer
5th Jun 20184:45 pmRNSFundraising
24th May 20187:00 amRNSDistribution Agreement with Stable Arm Sdn. Bhd.
9th May 20187:00 amRNSAgreement with Rightek Co., Ltd.
4th May 201811:25 amRNSResult of AGM
4th May 20187:00 amRNSAGM Statement
12th Apr 20187:00 amRNSMicrosaic signs Agreement with Knauer
6th Apr 20187:00 amRNSNotice of AGM and Posting of Annual Report
28th Mar 20187:00 amRNSAgreement with Unimicro Technologies Inc.
23rd Mar 20184:45 pmRNSHolding(s) in Company
21st Mar 20187:00 amRNSCommercial contract with CPI Innovation Services
5th Mar 20187:00 amRNSFinal Results
21st Feb 20187:00 amRNSNotice of Results
3rd Jan 20187:00 amRNSAward of Options
19th Dec 20177:00 amRNSDirectorate Change
13th Dec 20177:00 amRNSResearch agreement with global biopharma partner
28th Sep 20177:00 amRNSInterim Results
25th Sep 20177:00 amRNSAppointment of CEO
13th Sep 20177:00 amRNSMicrosaic to Exhibit at BioProcess International
14th Aug 20177:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.